| Literature DB >> 20655214 |
Tianmin Zhu1, Mahdi B Fawzi, Michael Flint, Fangming Kong, Jan Szeliga, Russ Tsao, Anita Y M Howe, Weitao Pan.
Abstract
The union of HCV-796, a potent selective HCV NS5B polymerase inhibitor, and Ribavirin, a molecule with activities against a wide spectrum of viruses, resulted in a class of new anti-HCV agents with a sequential triple inhibitory mechanism. Copyright 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20655214 DOI： 10.1016/j.bmcl.2010.06.156
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN： 0960-894X Impact factor: 2.823